Anavex submits Nasdaq compliance plan to regain listing after late Q1 filing

ANAVEX LIFE SCIENCES CORP.

Submitted compliance plan on July 20, 2026 to Nasdaq Staff regarding late Form 10-Q for March 31, 2026.
Plan addresses non-compliance with Nasdaq Listing Rule 5250(c)(1) for timely periodic reports.
Nasdaq Staff reviewing plan; if accepted, extension may be granted; if not, hearing available.
No immediate effect on listing; common stock continues trading on Nasdaq under symbol AVXL.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.